Sign inGet started

Katz Richard D

Insider CIK 1293577 · ARGS Vice President and CFO · LQDA Chief Financial Officer · ALNA Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ALNA Allena Pharmaceuticals, In A Award deriv2022-02-012022-02-02255,000— $0255,000SEC↗
ALNA Allena Pharmaceuticals, In A Award deriv2021-02-012021-02-02400,000— $0400,000SEC↗
LQDA Liquidia Technologies Inc A Award deriv2020-03-182020-03-2043,333— $043,333SEC↗
LQDA Liquidia Technologies Inc A Award2020-03-182020-03-2010,833— $010,833SEC↗
LQDA Liquidia Technologies Inc A Award deriv2019-05-222019-05-22155,000— $0155,000SEC↗
ARGS ARGOS THERAPEUTICS INC D To issuer2018-04-252018-04-2522,629— $09,697SEC↗
ARGS ARGOS THERAPEUTICS INC A Award2018-03-282018-04-0222,629— $032,326SEC↗
ARGS ARGOS THERAPEUTICS INC S Sale2018-01-102018-01-12104,435$0.16 $16.7K193,959SEC↗
ARGS ARGOS THERAPEUTICS INC S Sale2018-01-092018-01-12104,435$0.16 $16.7K193,959SEC↗
ARGS ARGOS THERAPEUTICS INC S Sale2018-01-032018-01-05101,228$0.16 $16.2K298,394SEC↗
ARGS ARGOS THERAPEUTICS INC A Award2017-08-302017-08-31395,664— $0399,622SEC↗
ARGS ARGOS THERAPEUTICS INC A Award deriv2017-01-192017-01-23105,000— $0105,000SEC↗
ARGS ARGOS THERAPEUTICS INC A Award2017-01-192017-01-233,958— $03,958SEC↗
ARGS ARGOS THERAPEUTICS INC A Award deriv2016-07-112016-07-13300,000— $0300,000SEC↗